Word

SENZER

Status

Dead

Status Code

710

Status Date

Friday, June 21, 2024

Serial Number

86745982

Registration Number

5348473

Registration Date

Tuesday, December 5, 2017

Mark Type

4

Filing Date

Wednesday, September 2, 2015

Published for Opposition

Tuesday, September 19, 2017

Cancellation Date

Friday, June 21, 2024

Trademark Owner History

SENZER LIMITED -
Kinhold IP Limited - Original Registrant

Classifications

5 Pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal, and cardiovascular disorders; substances adapted for medical use, namely, cannabinoids for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, other intestinal, neurological and cardiovascular disorders; vaccines for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and intestinal and cardiovascular disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; drug delivery agents in the form of powders, capsules, inhalers, that facilitate the delivery of pharmaceutical preparations; none of the aforesaid being for or in relation to preparations for the treatment of liver diseases

10 Inhalers for medical purposes; filters for inhalers for medical purposes; inhalers for medical use; inhalers for therapeutic use; drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; microneedle arrays for delivering medications; hypodermic syringes for injections for medical purposes; all of the aforesaid for use in delivering pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and intestinal, neurological and cardiovascular disorders; none of the aforesaid being for or in relation to preparations for the treatment of liver diseases

Trademark Events

Dec 15, 2015

Assigned To Examiner

Sep 5, 2015

New Application Entered

Sep 8, 2015

New Application Office Supplied Data Entered

Dec 10, 2015

Teas Voluntary Amendment Received

Dec 15, 2015

Assigned To Lie

Dec 15, 2015

Preliminary/Voluntary Amendment - Entered

Dec 17, 2015

Assigned To Examiner

Dec 22, 2015

Non-Final Action Written

Dec 22, 2015

Non-Final Action E-Mailed

Dec 22, 2015

Notification Of Non-Final Action E-Mailed

Jun 22, 2016

Teas Response To Office Action Received

Jun 23, 2016

Correspondence Received In Law Office

Jun 23, 2016

Teas/Email Correspondence Entered

Jul 13, 2016

Approved For Pub - Principal Register

Jul 18, 2016

Law Office Publication Review Completed

Jul 21, 2016

Previous Allowance Count Withdrawn

Jul 21, 2016

Withdrawn From Pub - Managing Attorney Request

Jul 21, 2016

Suspension Letter Written

Jul 21, 2016

Letter Of Suspension E-Mailed

Jul 21, 2016

Notification Of Letter Of Suspension E-Mailed

Jan 30, 2017

Suspension Checked - To Attorney For Action

Feb 1, 2017

Suspension Inquiry Written

Feb 1, 2017

Inquiry To Suspension E-Mailed

Feb 1, 2017

Notification Of Inquiry As To Suspension E-Mailed

Jul 24, 2017

Teas Response To Suspension Inquiry Received

Jul 26, 2017

Correspondence Received In Law Office

Jul 26, 2017

Teas/Email Correspondence Entered

Aug 7, 2017

Approved For Pub - Principal Register

Aug 11, 2017

On Hold - Electronic Record Review Required

Aug 14, 2017

Electronic Record Review Complete

Aug 30, 2017

Notification Of Notice Of Publication E-Mailed

Sep 19, 2017

Published For Opposition

Sep 19, 2017

Official Gazette Publication Confirmation E-Mailed

Dec 5, 2017

Registered-Principal Register

Aug 26, 2020

Automatic Update Of Assignment Of Ownership

Dec 5, 2022

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Sep 14, 2023

Teas Withdrawal Of Attorney Received

Sep 14, 2023

Withdrawal Of Attorney Granted

Jun 21, 2024

Cancelled Sec. 8 (6-Yr)